H. Torii

发表

Differential effects of LPS and TGF-beta on the production of IL-6 and IL-12 by Langerhans cells, splenic dendritic cells, and macrophages.

H. Mitsui, Y. Tada, H. Fujita, 2004, Cytokine.

Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study

A. Utani, H. Nakagawa, M. Muto, 2016, The Journal of dermatology.

Long‐term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma

H. Nakagawa, H. Torii, 2011, The Journal of dermatology.

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.

H. Nakagawa, H. Torii, 2010, Journal of dermatological science.

A novel diacylglycerol acyltransferase (DGAT2) is decreased in human psoriatic skin and increased in diabetic mice.

K. Okubo, M. Seishima, S. Kawasaki, 2003, Biochemical and biophysical research communications.

Japanese guidance for use of biologics for psoriasis (the 2019 version)

H. Nakagawa, M. Komine, M. Ohtsuki, 2020, The Journal of dermatology.

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

D. Shrom, L. Ferris, R. Burge, 2020, Dermatology and Therapy.

Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: An analysis of Japanese clinical trials of infliximab

H. Nakagawa, H. Torii, T. Yoshinari, 2012, The Journal of dermatology.

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

M. Lebwohl, A. Armstrong, M. Gooderham, 2019, Dermatology and Therapy.

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.

Koichiro Nakamura, K. Matsushima, H. Mitsui, 2001, The Journal of allergy and clinical immunology.

A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation

M. Sugaya, H. Fujita, K. Tamaki, 2004, The British journal of dermatology.

Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris.

M. Komine, H. Mitsui, Y. Tada, 2002, Journal of dermatological science.

Eotaxin gene single nucleotide polymorphisms in the promoter and exon regions are not associated with susceptibility to atopic dermatitis, but two of them in the promoter region are associated with serum IgE levels in patients with atopic dermatitis.

Koichiro Nakamura, T. Sekiya, H. Fujita, 2002, Journal of dermatological science.

Langerhans Cells Antigen-presenting Capability of Epidermal Catecholamines Inhibit The

R. Granstein, J. Hosoi, H. Torii, 2022 .

Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12.

G. Trinchieri, F. Fox, M. Kubin, 1997, The Journal of investigative dermatology.

The −431C>T polymorphism of thymus and activation‐regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients

Koichiro Nakamura, M. Komine, T. Sekiya, 2004, Experimental dermatology.

Lack of association of CCR4 single nucleotide polymorphism with atopic dermatitis in Japanese patients.

K. Ohta, Koichiro Nakamura, T. Sekiya, 2004, Acta dermato-venereologica.

Lack of association of CCR3 single nucleotide polymorphism with atopic dermatitis in Japanese population.

K. Ohta, Koichiro Nakamura, T. Sekiya, 2003, Journal of dermatological science.

IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line.

Koichiro Nakamura, M. Komine, K. Tamaki, 2002, Cytokine.

Signaling through CD40 ligand decreases CD80 expression on murine Langerhans cells and enhances IL-12 p40 production.

Koichiro Nakamura, Y. Tada, M. Sugaya, 2005, Biochemical and biophysical research communications.

Regulation of cytokine expression in macrophages and the Langerhans cell‐like line XS52 by calcitonin gene‐related peptide

S. Beissert, F. Fox, A. Rook, 1997, Journal of leukocyte biology.

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial

H. Ihn, K. Papp, C. Nishigori, 2017, The Journal of dermatology.

Cytotoxic T lymphocyte antigen-4 gene (CTLA4) polymorphisms in Japanese patients with psoriasis vulgaris.

M. Komine, H. Mitsui, Y. Tada, 2003, Journal of dermatological science.

Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells

Koichiro Nakamura, M. Komine, H. Mitsui, 2003 .

Serum macrophage‐derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis

Koichiro Nakamura, M. Komine, H. Mitsui, 2002, Clinical and experimental immunology.

Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity.

R. Crystal, N. Hackett, N. Topf, 1999, The Journal of investigative dermatology.

The effect of neuropeptides/hormones on Langerhans cells.

R. Granstein, K. Tamaki, H. Torii, 1999, Journal of dermatological science.

Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves.

Z. Yan, R. Granstein, J. Hosoi, 1997, The Journal of investigative dermatology.

Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.

Koichiro Nakamura, M. Komine, H. Mitsui, 2003, The Journal of allergy and clinical immunology.

Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12.

G. Trinchieri, F. Fox, M. Kubin, 1997, Journal of Investigative Dermatology.

Significant elevation of serum levels of eotaxin‐3/CCL26, but not of eotaxin‐2/CCL24, in patients with atopic dermatitis: serum eotaxin‐3/CCL26 levels reflect the disease activity of atopic dermatitis

Koichiro Nakamura, M. Komine, H. Mitsui, 2003, Clinical and experimental immunology.

Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma.

Koichiro Nakamura, H. Mitsui, Y. Tada, 2003, Cytokine.

Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.

Y. Tamada, Y. Tada, Y. Kuwano, 2003, Journal of dermatological science.

Histiocytic Necrotizing Lymphadenitis (Kikuchi's Disease): The Necrotic Appearance of the Lymph Node Cells Is Caused by Apoptosis

S. Imakado, K. Iozumi, S. Shimada, 1999, The Journal of dermatology.

Prevalence of atopic dermatitis in Japanese elementary schoolchildren

T. Tezuka, H. Iizuka, K. Urabe, 2005, The British journal of dermatology.

Calcitonin gene-related peptide and Langerhans cell function.

R. Granstein, J. Hosoi, A. Asahina, 1997, The journal of investigative dermatology. Symposium proceedings.

Dermatological side‐effects of telaprevir‐based triple therapy for chronic hepatitis C in phase III trials in Japan

M. Ohtsuki, H. Sueki, H. Kumada, 2013, The Journal of dermatology.

English version of Japanese guidance for use of biologics for psoriasis (the 2022 version)

M. Komine, M. Ohtsuki, H. Yotsuyanagi, 2022, The Journal of dermatology.

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.

Robert Wolk, Steven R Feldman, James G Krueger, 2016, Journal of the American Academy of Dermatology.

Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

S. Rafii, R. Crystal, M. Moore, 1997, The Journal of experimental medicine.

Trichogenic trichoblastoma arising on the supraclavicular fossa with an immunohistochemical study of cytokeratin expression

S. Harada, T. Matsuyama, T. Ohnishi, 1997, Clinical and experimental dermatology.

Trichoblastic fibroma. A case report and an immunohistochemical study of cytokeratin expression.

S. Harada, T. Matsuyama, H. Torii, 1996, The American Journal of dermatopathology.

Cloning of a Gene for a Novel Epithelium-specific Cytosolic Phospholipase A2, cPLA2δ, Induced in Psoriatic Skin*

K. Okubo, M. Seishima, S. Kawasaki, 2004, Journal of Biological Chemistry.

Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris.

Koichiro Nakamura, M. Komine, H. Mitsui, 2002, Journal of dermatological science.

Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells1

J. Wagner, R. Granstein, J. Hosoi, 2002, The Journal of Immunology.

Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate‐to‐severe psoriasis patients: 12‐week results from two phase III trials

Y. Poulin, L. Guenther, C. Paul, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Japanese guidance for use of biologics for psoriasis (the 2013 version)

H. Nakagawa, Hidetoshi Takahashi, M. Komine, 2013, The Journal of dermatology.

Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post‐marketing surveillance

H. Nakagawa, M. Ohtsuki, H. Torii, 2016, The Journal of dermatology.

An Immunohistochemical Study

H. Nakagawa, H. Torii, Y. Ishibashi, 2015 .

Interferon‐α (INF‐α) and Etretinate in the Treatment of Mycosis Fungoides

H. Nakanishi, T. Matsuyama, H. Torii, 1994 .

Identification and characterization of a novel component of the cornified envelope, cornifelin.

Satoshi Kawasaki, Kousaku Okubo, Hiroshi Mitsui, 2004, Biochemical and biophysical research communications.

A Randomized, Open-Label, Multicenter Trial of Topical Tacrolimus for the Treatment of Pruritis in Patients with Atopic Dermatitis

Koichiro Nakamura, Y. Ohya, S. Takeuchi, 2012, Annals of dermatology.

Genetic polymorphisms in HLA-A, -B, -C and -DR antigens in Japanese patients with palmoplantar pustulosis.

H. Nakagawa, K. Tokunaga, T. Juji, 1994, Dermatology.

Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients.

Koichiro Nakamura, T. Sekiya, H. Fujita, 2002, Journal of dermatological science.

Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma.

Koichiro Nakamura, H. Mitsui, Y. Tada, 2003, Cytokine.

Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey

M. Kishimoto, H. Torii, H. Noguchi, 2022, The Journal of dermatology.

Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study

H. Nakagawa, M. Ohtsuki, H. Hase, 2016, The Journal of dermatology.

Lack of Association between the Promoter Polymorphisms at Positions –308 and –238 of the Tumor Necrosis Factor Alpha Gene and Psoriasis vulgaris in Japanese Patients

Koichiro Nakamura, M. Komine, H. Mitsui, 2004, Dermatology.

Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans

N. Hattori, Y. Tamada, T. Kadono, 2006, Clinical and experimental dermatology.

Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies.

B. Elewski, R. Burge, L. Iversen, 2021, Journal of Drugs in Dermatology.

English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis

M. Komine, M. Ohtsuki, H. Yotsuyanagi, 2023, The Journal of dermatology.

Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells.

Koichiro Nakamura, M. Komine, H. Mitsui, 2003, Journal of dermatological science.

Expression of beta-adrenergic receptors by the langerhans cell-like line XS52

R. Granstein, J. Hosoi, H. Torii, 1998 .

Beta-endorphin regulation of cytokine expression in the Langerhans cell-like cell line XS52 and freshly obtained Langerhans cells

R. Granstein, T. Tsuchiya, J. Hosoi, 1998 .

Osteoarthritis in 84 Japanese patients with palmoplantar pustulosis.

H. Nakagawa, H. Torii, Y. Ishibashi, 1994, Journal of the American Academy of Dermatology.

Case of immunoglobulin G4‐related disease with unusual cutaneous manifestation

H. Torii, H. Fujii, 2017, The Journal of dermatology.